116 related articles for article (PubMed ID: 12810618)
1. 10 years of mouse cancer modifier loci: human relevance.
Dragani TA
Cancer Res; 2003 Jun; 63(12):3011-8. PubMed ID: 12810618
[TBL] [Abstract][Full Text] [Related]
2. Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.
Peissel B; Zaffaroni D; Pazzaglia S; Manenti G; Zanesi N; Zedda I; Rebessi S; Covelli V; Dragani TA; Saran A
Mamm Genome; 2001 Apr; 12(4):291-4. PubMed ID: 11309660
[TBL] [Abstract][Full Text] [Related]
3. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression.
Manenti G; Gariboldi M; Fiorino A; Zanesi N; Pierotti MA; Dragani TA
Cancer Res; 1997 Oct; 57(19):4164-6. PubMed ID: 9331067
[TBL] [Abstract][Full Text] [Related]
4. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
[TBL] [Abstract][Full Text] [Related]
6. Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice.
Nagase H; Mao JH; de Koning JP; Minami T; Balmain A
Cancer Res; 2001 Feb; 61(4):1305-8. PubMed ID: 11245425
[TBL] [Abstract][Full Text] [Related]
7. Genetic mapping of cancer susceptibility/resistance loci in the mouse.
Manenti G; De Gregorio L; Gariboldi M; Falvella FS; Zanesi N; Pierotti MA; Dragani TA
Recent Results Cancer Res; 1998; 154():292-7. PubMed ID: 10027009
[TBL] [Abstract][Full Text] [Related]
8. Linkage disequilibrium mapping of novel lung tumor susceptibility quantitative trait loci in mice.
Wang D; Lemon WJ; You M
Oncogene; 2002 Oct; 21(44):6858-65. PubMed ID: 12360413
[TBL] [Abstract][Full Text] [Related]
9. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Calvisi DF; Virdis P; Bosinco GM; Frau M; Seddaiu MA; Ladu S; Feo F
Cancer Res; 2002 Aug; 62(15):4459-63. PubMed ID: 12154055
[TBL] [Abstract][Full Text] [Related]
10. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer.
Demant P
Nat Rev Genet; 2003 Sep; 4(9):721-34. PubMed ID: 12951573
[TBL] [Abstract][Full Text] [Related]
11. Modifier locus for exencephaly in Cecr2 mutant mice is syntenic to the 10q25.3 region associated with neural tube defects in humans.
Davidson CE; Li Q; Churchill GA; Osborne LR; McDermid HE
Physiol Genomics; 2007 Oct; 31(2):244-51. PubMed ID: 17623803
[TBL] [Abstract][Full Text] [Related]
12. Identification of an X-linked locus modifying mouse skin tumor susceptibility.
George K; Iacobucci A; Uitto J; O'Brien TG
Mol Carcinog; 2005 Nov; 44(3):212-8. PubMed ID: 16086382
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association and fine mapping of genetic loci predisposing to colon carcinogenesis in mice.
Liu P; Lu Y; Liu H; Wen W; Jia D; Wang Y; You M
Mol Cancer Res; 2012 Jan; 10(1):66-74. PubMed ID: 22127497
[TBL] [Abstract][Full Text] [Related]
14. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.
Ruivenkamp CA; van Wezel T; Zanon C; Stassen AP; Vlcek C; Csikós T; Klous AM; Tripodis N; Perrakis A; Boerrigter L; Groot PC; Lindeman J; Mooi WJ; Meijjer GA; Scholten G; Dauwerse H; Paces V; van Zandwijk N; van Ommen GJ; Demant P
Nat Genet; 2002 Jul; 31(3):295-300. PubMed ID: 12089527
[TBL] [Abstract][Full Text] [Related]
15. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
[TBL] [Abstract][Full Text] [Related]
16. [Genetic modifier loci of transplanted SP2/0 tumors in mice].
Ji LL; Qian XW; Tan XL
Ai Zheng; 2008 Jul; 27(7):703-9. PubMed ID: 18606062
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific imbalance mapping at human orthologs of mouse susceptibility to colon cancer (Scc) loci.
Gerber MM; Hampel H; Zhou XP; Schulz NP; Suhy A; Deveci M; Çatalyürek ÜV; Ewart Toland A
Int J Cancer; 2015 Nov; 137(10):2323-31. PubMed ID: 25973956
[TBL] [Abstract][Full Text] [Related]
18. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA genes are frequently located near mouse cancer susceptibility loci.
Sevignani C; Calin GA; Nnadi SC; Shimizu M; Davuluri RV; Hyslop T; Demant P; Croce CM; Siracusa LD
Proc Natl Acad Sci U S A; 2007 May; 104(19):8017-22. PubMed ID: 17470785
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses.
Roper RJ; Weis JJ; McCracken BA; Green CB; Ma Y; Weber KS; Fairbairn D; Butterfield RJ; Potter MR; Zachary JF; Doerge RW; Teuscher C
Genes Immun; 2001 Nov; 2(7):388-97. PubMed ID: 11704805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
